Medikaloka Hermina Pt Stock Fundamentals
| HEAL Stock | IDR 1,515 35.00 2.36% |
Medikaloka Hermina PT fundamentals help investors to digest information that contributes to Medikaloka Hermina's financial success or failures. It also enables traders to predict the movement of Medikaloka Stock. The fundamental analysis module provides a way to measure Medikaloka Hermina's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medikaloka Hermina stock.
Medikaloka |
Medikaloka Hermina PT Company Profit Margin Analysis
Medikaloka Hermina's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Medikaloka Hermina Profit Margin | 0.1 % |
Most of Medikaloka Hermina's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medikaloka Hermina PT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Medikaloka Hermina PT has a Profit Margin of 0.0994%. This is 100.89% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The profit margin for all Indonesia stocks is 107.83% lower than that of the firm.
Medikaloka Hermina Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medikaloka Hermina's current stock value. Our valuation model uses many indicators to compare Medikaloka Hermina value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medikaloka Hermina competition to find correlations between indicators driving Medikaloka Hermina's intrinsic value. More Info.Medikaloka Hermina PT is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.50 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medikaloka Hermina PT is roughly 1.99 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medikaloka Hermina's earnings, one of the primary drivers of an investment's value.Medikaloka Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medikaloka Hermina's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medikaloka Hermina could also be used in its relative valuation, which is a method of valuing Medikaloka Hermina by comparing valuation metrics of similar companies.Medikaloka Hermina is currently under evaluation in profit margin category among its peers.
Medikaloka Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0704 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 23.44 T | |||
| Shares Outstanding | 14.48 B | |||
| Shares Owned By Insiders | 51.07 % | |||
| Shares Owned By Institutions | 7.10 % | |||
| Price To Earning | 7.42 X | |||
| Price To Book | 6.72 X | |||
| Price To Sales | 4.66 X | |||
| Revenue | 5.82 T | |||
| Gross Profit | 2.71 T | |||
| EBITDA | 1.9 T | |||
| Net Income | 1 T | |||
| Cash And Equivalents | 590.19 B | |||
| Cash Per Share | 40.20 X | |||
| Total Debt | 1.47 T | |||
| Debt To Equity | 0.41 % | |||
| Current Ratio | 1.59 X | |||
| Book Value Per Share | 230.87 X | |||
| Cash Flow From Operations | 1.86 T | |||
| Earnings Per Share | 32.62 X | |||
| Target Price | 1693.1 | |||
| Number Of Employees | 14.38 K | |||
| Beta | 0.4 | |||
| Market Capitalization | 22.15 T | |||
| Total Asset | 7.59 T | |||
| Z Score | 9.0 | |||
| Annual Yield | 0 % | |||
| Net Asset | 7.59 T | |||
| Last Dividend Paid | 6.0 |
About Medikaloka Hermina Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medikaloka Hermina PT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medikaloka Hermina using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medikaloka Hermina PT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.PT Medikaloka Hermina Tbk operates a network of general hospitals in Indonesia. The company was founded in 1999 and is based in Jakarta, Indonesia. Medikaloka Hermina operates under Medical Care Facilities classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 10547 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Medikaloka Stock
Medikaloka Hermina financial ratios help investors to determine whether Medikaloka Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medikaloka with respect to the benefits of owning Medikaloka Hermina security.